pocketful logo light
pocketful logo light
Kilitch Drugs (India) Ltd logo

Kilitch Drugs (India) Ltd

NSE: KILITCH BSE: 524500

₹185.97

(0.51%)

Fri, 18 Sept 2026, 05:53 am

Kilitch Drugs (India) Share Price Live Chart

1 Day

(0.51%)

No Result Found

Summary

  • Market Cap (in Cr)

    633.33

  • Net Profit (in Cr)

    24.94

  • P/B

    2.87

  • Sector P/E

    33.76

  • P/E

    21.77

  • EV/EBITDA

    14.47

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    11.68

  • ROCE

    15.57

  • Debt/Equity

    0.21

  • EPS (TTM)

    8.63

  • Dividend Yield

    0

  • Book Value

    79.99

  • Interest Cover

    6.73

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters63.7763.7763.7769.2369.23
FII0.0000.000.000
DII0.000.000.000.000.00
Public36.2236.2336.2330.7630.77
Government00000

Read More

Technical Analysis

RSI

61.81

MACD

3.07

50 DMA

180.90

200 DMA

169.72

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic263.92220.33197.49176.74153.90133.1589.56
Fibonacci220.33203.68193.39176.74160.09149.80133.15
Camarilla186.63182.63178.64176.74170.64166.65162.65

Pivots Level: Classic

R3

+87.18

263.92

R2

+43.59

220.33

R1

+20.74

197.49

176.74
176.74
Pivot Point
LTP: 190

S1

-22.85

153.90

S2

-43.59

133.15

S3

-87.18

89.56

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    186.05

  • 20-EMA

    182.84

  • 30-EMA

    181.75

  • 50-EMA

    180.67

  • 100-EMA

    177.69

  • 200-EMA

    175.69

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
15 May 2026board-meetingsAccounts, Quarterly Results
18 Mar 2026bonus1:1 Bonus Issue of Equity Shares24 Mar 2026
11 Feb 2026egm
11 Feb 2026board-meetingsQuarterly Results, Bonus Issue, EGM, Increase in Authorised Capital
13 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
01 Sept 2025agm
09 Jul 2025rights2:23 Rights Issue of Equity Shares15 Jul 2025
15 Jun 2025rightsRight Issue of Equity Shares15 Jul 2025
26 Aug 2024agm
19 Aug 2024agmAnnual General Meeting20 Sept 2024

Read More

Peer Comparison

Kilitch Drugs (India) Ltd logo

Kilitch Drugs (India) Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Kilitch Drugs (India) Ltd About

Kilitch Drugs (India) in the manufacturing, supplying and marketing of broad range of pharmaceutical formulation in the various dosage from like Solid, Liquid and Parental across the globe with over three decades of experience.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1992

Headquarters

CEO

Mukund P Mehta

Employees

Contact

Website icon

Website

http://www.kilitch.com

Email icon

Email

info@kilitch.com

Phone icon

Phone

91-022-27670322/27680913/65144185

Location icon

Location

C-301/2 MIDC TTC Indl Area, Pawane Village, Thane, Maharashtra, 400705

Read More

Kilitch Drugs (India) Ltd Company History

YearHistory
2009
  • The Company received a GOLD AWARD for Quality Excellence.
2010
  • The Company's Equity Shares were listed at NSE.
2011
2015
  • Kilitch Drugs entered a joint venture with a local firm in Ethiopia.
2021
  • Kilitch Drugs started production of Cephalosporins Injectables at Ethiopia Plant on 26th July.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
SHRENI SHARES PVTbulkSell117495405.5828 Oct 2025
SHRENI SHARES PVTbulkBuy32332401.8228 Oct 2025
SHAH DIPAK KANAYALALbulkSell6669996.3506 Mar 2018
BP FINTRADE PRIVATE LIMITEDbulkBuy7821496.3606 Mar 2018
BP FINTRADE PRIVATE LIMITEDbulkSell5681198.9806 Mar 2018
SHAH DIPAK KANAYALALbulkSell80000115.8801 Mar 2018
RONAK BANSALbulkSell72184131.2827 Feb 2018
RONAK BANSALbulkBuy72184122.927 Feb 2018
ANKUR TUKARAM MAYEKARbulkBuy15020085.2322 Jan 2018
ARUNA DINESH SHAHbulkBuy15040089.3222 Jan 2018

Read More

Kilitch Drugs (India) Ltd News

Kilitch Drugs sets AGM date, closes books

Kilitch Drugs (India) Limited has scheduled its 34th Annual General Meeting for August 27, 2026. The company will close its share transfer books from August 20 to August 27. M/s Arvind Kumar & Co. is reappointed as Cost Auditor.

28 Jul 2026

companies

Kilitch Drugs Begins Nutraceutical Output at Raigad Plant

Kilitch Drugs has commenced nutraceutical production at its newly established manufacturing facility located in Raigad, Maharashtra.

17 Jun 2026

companies

Kilitch Drugs confirms no share encumbrance in FY26

Kilitch Drugs (India) Limited confirmed no encumbrance over shares held by promoters during FY26. The disclosure was made under SEBI regulations on April 4, 2026.

21 May 2026

companies

Kilitch Drugs Q4 Profit Jumps to 145M Rupees YoY

Kilitch Drugs posts Q4 consolidated net profit of 145M rupees vs 104M YoY, with revenue rising to 900M rupees vs 612M and EBITDA margin expanding to 24.7% vs 23.8%.

15 May 2026

companies

Kilitch Drugs Board Meeting Set for May 15, 2026

Kilitch Drugs (India) Ltd schedules board meeting on May 15, 2026 to approve audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026.

07 May 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Kilitch Drugs (India) Ltd?

    As of 18/09/2026 at 11:23 AM, Kilitch Drugs (India) Ltd shares are trading at ₹185.97.

  • 2.What is the market cap. of Kilitch Drugs (India) Ltd?

    As of 18/09/2026, the market capitalization of Kilitch Drugs (India) Ltd is ₹641.72 crore.

  • 3.When was Kilitch Drugs (India) Ltd founded?

    Kilitch Drugs (India) Ltd was founded in 1992.

  • 4.What are the P/E and P/B ratios of Kilitch Drugs (India) Ltd?

    As of 18/09/2026, Kilitch Drugs (India) Ltd has a P/E ratio of 21.28 and a P/B ratio of 2.87.

  • 5.How can I buy shares of Kilitch Drugs (India) Ltd?

    You can buy shares of Kilitch Drugs (India) Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Kilitch Drugs (India) Ltd?

    As of March,2026, promoters hold 63.77% in Kilitch Drugs (India) Ltd, while FIIs, DIIs and public shareholders hold 0.00%, 0.00% and 36.22%, respectively.

  • 7.Does Kilitch Drugs (India) Ltd pay dividends?

    No, Kilitch Drugs (India) Ltd does not pay dividends to eligible shareholders currently.

  • 8.What are the latest financial results of Kilitch Drugs (India) Ltd?

    For January,2024, Kilitch Drugs (India) Ltd reported revenue of ₹198.00 crore and a net profit of ₹26.70 crore.

  • 9.What is the Stock symbol of Kilitch Drugs (India) Ltd?

    KILITCH is the stock symbol of Kilitch Drugs (India) Ltd.

  • 10.Who is the CEO of Kilitch Drugs (India) Ltd?

    The CEO of Kilitch Drugs (India) Ltd is Mukund P Mehta.

Open Your Free Demat Account

Enter your phone number